This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,873.20 fixed-price contract is for the delivery of GILENYA 0.5 mg capsules, a specialty medication used for the treatment of multiple sclerosis. The award is not designated as a set-aside contract.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC valued at $750,000 with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities.
Generated 1/31/25, 9:23 AM